Bicara Therapeutics Inc. (BCAX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Bicara Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$9.76
−44.16% today
Market cap
$1.2B
Overall quality
44/100
Kronos AI 30-day
+25.5%
8 of 8 simulated paths end higher
Bicara Therapeutics Inc. (BCAX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.2B. It trades at $9.76, down 44.16% today. Its overall quality score is 44 out of 100, ranked against the whole US market. 8 analysts' average target of $33.33 implies +241.5% from today's price. Kronos AI's 30-day forecast is +25.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $33.33 |
| Low – high | $20.00 – $45.00 |
| Analysts | 8 |
| Upside to average | +241.5% |
Kronos AI 30-day forecast
| Expected close | $21.93 (+25.5%) |
| Likely range | +21.7% … +63.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 61 |
| Growth | 31 |
| Overall | 44 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.